申请人:Eli Lilly and Company
公开号:US11124496B2
公开(公告)日:2021-09-21
The present invention provides a compound of Formula (I) wherein X is selected from the group consisting of (CH2)2— and CH2—CH(CH3)—; Q is selected from the group consisting of C(CH3)2 and Formula (a); or a pharmaceutically acceptable salt thereof; compositions, methods to treat liver disease and NASH.
本发明提供了式(I)化合物,其中X选自由(CH2)2-和CH2-CH(CH3)-组成的组;Q选自由C(CH3)2和式(a)组成的组;或其药学上可接受的盐;治疗肝病和NASH的组合物和方法。